High materiality8/10
AbbVie price target raised to $273 from $265 at Canaccord
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Canaccord Genuity lifts ABBV target to $273 from $265; current price $230.06; upside implied.
- Canaccord target $273 vs price $230.06.
Key facts
- 01
Target: $273
- 02
Posted price: $230.06
- 03
Analyst firm: Canaccord Genuity
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.